This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jan 18;57(3):290-1.

doi: 10.1016/j.jacc.2010.08.632.

No role for triple antiplatelet therapy?

David Antoniucci

PMID: 21232665
DOI: 10.1016/j.jacc.2010.08.632

Free article

Editorial

No role for triple antiplatelet therapy?

David Antoniucci. J Am Coll Cardiol. 2011.

Free article

. 2011 Jan 18;57(3):290-1.

doi: 10.1016/j.jacc.2010.08.632.

Author

David Antoniucci

PMID: 21232665
DOI: 10.1016/j.jacc.2010.08.632

No abstract available

PubMed Disclaimer

Comment on

Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
Suh JW, Lee SP, Park KW, Lee HY, Kang HJ, Koo BK, Cho YS, Youn TJ, Chae IH, Choi DJ, Rha SW, Bae JH, Kwon TG, Bae JW, Cho MC, Kim HS. Suh JW, et al. J Am Coll Cardiol. 2011 Jan 18;57(3):280-9. doi: 10.1016/j.jacc.2010.08.631. J Am Coll Cardiol. 2011. PMID: 21232664 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information